Promising natural compounds as possible means of prevention and treatment of the novel coronavirus infection caused by the SARS-CoV-2 virus
https://doi.org/10.25789/YMJ.2020.71.25
Abstract
The literature review presents the accumulated scientific experience of many researchers searching for plant-derived metabolites with potential action against SARS-CoV-2. Unlike synthetic drugs, herbal antiviral drugs do not require labor-intensive pharmaceutical synthesis and are more affordable and relatively safe. In this work, we searched for promising natural compounds as possible means of preventing and treating a new coronavirus infection caused by the SARS-CoV-2 virus.
About the Authors
V. M. Nikolaev
ЯНЦ КМП
Russian Federation
Russian Federation
N. K. Chirikova
Ин-та естественных наук СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
S. I. Sofronova
ЯНЦ КМП
Russian Federation
Russian Federation
E. K. Rumyancev
ЯНЦ КМП
Russian Federation
Russian Federation
A. G. Vasileva
СВФУ им. М.К. Аммосова
Russian Federation
Russian Federation
A. N. Romanova
ЯНЦ КМП
Russian Federation
Russian Federation
References
1. Kuznetsova L.V. Abstract of the flora of Yakutia: Vascular plants / L.V. Kuznetsov, V.I. Zakharova - Novosibirsk: Science, 2012. - 272 р.
2. Makarov A.A. Medicinal plants of Yakutia and prospects for their development. / A.A. Makarov. - Novosibirsk: Publishing house of the Siberian Branch of the Russian Academy of Sciences. - 2002. - Р. 264.
3. Makarov A.A. Biologically active substances in plants of Yakutia / A.A. Makarov. - Yakutsk: YANTSSO AN USSR. - 1989. - Р. 156.
4. Makarov A.A. Methods of search and study of medicinal plants / A.A. Makarov. - Yakutsk: Yakut. book publishing house, 1981. - P. 66.
5. Pavlovskaya N.E. The functional role of plant lectins as a prerequisite for use in biotechnology / N.E. Pavlovskaya, I.N. Gagarin // Chemistry of vegetable raw materials. -2017. - № 1. - Р. 21-35.
6. Samarin V.P. On the total content of alkaloids in some plants of Yakutia. Problems of modern botany / V.P. Samarin. - M .: Science, 1965. - V.2. - P. 200-205.
7. Abian O, Ortega-Alarcon D, Jimenez-Alesanco A. et al. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening [published online ahead of print, 2020 Jul 31]. Int J Biol Macromol. 2020;S0141-8130(20)33997-0. doi: 10.1016/j.ijbiomac.2020.07.235
8. Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr. 2020;14(4):407-412. doi:10.1016/j.dsx.2020.04.020
9. Bouchentouf S., Missoum N. Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study. 2020
10. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382(19):1787- 1799. doi:10.1056/NEJMoa2001282
11. Cao P, Wu S, Wu T, et al. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic. Carbohydr Polym. 2020;240:116346. doi: 10.1016/j.carbpol.2020.116346
12. Chen L, Li J, Luo C, et al. Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL (pro): structure-activity relationship studies reveal salient pharmacophore features. Bioorg Med Chem. 2006;14(24):8295-8306. doi:10.1016/j.bmc.2006.09.014
13. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097-1100. doi:10.1093/cvr/cvaa078
14. Cho JK, Curtis-Long MJ, Lee KH, et al. Geranylated flavonoids displaying SARSCoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorg Med Chem. 2013;21(11):3051-3057. doi:10.1016/j.bmc.2013.03.027
15. de Haan CA, Rottier PJ. Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 2005;64:165-230. doi:10.1016/S0065-3527(05)64006-7
16. de Oliveira PG, Termini L, Durigon EL, Lepique AP, Sposito AC, Boccardo E. Diacerein: A potential multi-target therapeutic drug for COVID-19. Med Hypotheses. 2020;144:109920. doi:10.1016/j.mehy.2020.109920
17. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523-534. doi:10.1038/nrmicro.2016.81
18. Ding Y, Chen L, Wu W, Yang J, Yang Z, Liu S. Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway. Microbes Infect. 2017;19(12):605-615. doi:10.1016/j.micinf.2017.08.009
19. Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach [published online ahead of print, 2020 May 5]. J Biomol Struct Dyn. 2020;1-7. doi:10.10 80/07391102.2020.1760136
20. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020; 127:104362. doi: 10.1016/j.jcv.2020.104362
21. Gorbalenya A.E., Baker S.C., Baric R.S. et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019- nCoV and naming it SARS-CoV-2. Nat. Microbiol. 02.03.2020. DOI:10.1038/s41564-020-0695-z.
22. Gupta PC, Kumar MP, Ram J. COVID-19 pandemic from an ophthalmology point of view. Indian J Med Res. 2020;151(5):411-418. doi:10.4103/ijmr.IJMR_1369_20
23. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966;121(1):190-193. doi:10.3181/00379727-121-30734
24. Hilgenfeld R, Anand K, Mesters JR, et al. Structure and dynamics of SARS coronavirus main proteinase (Mpro). Adv Exp Med Biol. 2006;581:585-591. doi:10.1007/978-0-387- 33012-9_106
25. Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74(2):92-101. doi:10.1016/j.antiviral.2006.04.014
26. Hoffmann M, Kleine-Weber H, Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020;78(4):779-784. e5. doi:10.1016/j.molcel.2020.04.022
27. Hoffmann M., Kleine-Weber H.,Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020. pii: S0092-8674(20)30229-4. DOI:10.1016/j.cell.2020.02.052.
28. Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, Pöhlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A. 2005;102(22):7988- 7993. doi:10.1073/pnas.0409465102
29. Iftikhar H, Ali HN, Farooq S, Naveed H, Shahzad-Ul-Hussan S. Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach. Comput Biol Med. 2020;122:103848. doi:10.1016/j.compbiomed.2020.103848
30. Jahan I, Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk J Biol. 2020;44(3):228-241. Published 2020 Jun 21. doi:10.3906/biy-2005-114
31. Jin Z, Du X, Xu Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;10.1038/s41586-020-2223-y. doi:10.1038/s41586-020-2223-y
32. Kadil Y, Mouhcine M, Filali H. In Silico Investigation of the SARS CoV2 Protease with Thymoquinone Major Constituent of Nigella Sativa. Curr Drug Discov Technol. 2020;10.2174/15701 63817666200712164406. doi:10.2174/1570163817666200712164406
33. Kim DW, Seo KH, Curtis-Long MJ, et al. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J Enzyme Inhib Med Chem. 2014;29(1):59-63. doi:10.3109/14756366.2012.7 53591
34. King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. Order — Nidovirales. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. 2012. 784–794. DOI:10.1016/B978-0-12-384684- 6.00066-5.
35. Kishore V, Yarla NS, Bishayee A, et al. Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents. Curr Top Med Chem. 2017;17(8):845-857. doi:10.2174/1568026616666160927150452
Review
For citations:
Nikolaev V.M., Chirikova N.K., Sofronova S.I., Rumyancev E.K., Vasileva A.G., Romanova A.N. Promising natural compounds as possible means of prevention and treatment of the novel coronavirus infection caused by the SARS-CoV-2 virus. Yakut Medical Journal. 2020;(3):95-101. (In Russ.) https://doi.org/10.25789/YMJ.2020.71.25
Views:
6
Email this article 